Figure 2.
Kaplan–Meier survival curves examing the relationship between 12-week albumin and overall survival of patients with NSCLC treated with first-line (A) targeted therapy or (B) immunotherapy-based therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.